[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100126203":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":20,"locations":29,"responsibleParty":222,"collaborators":20,"id":224,"slug":225,"hasResults":226,"nctId":227,"briefTitle":228,"officialTitle":229,"acronym":20,"eligibilityCriteria":230,"healthyVolunteers":231,"sex":232,"minAge":233,"maxAge":20,"enrollmentInfo":234,"targetDuration":20,"studyType":237,"phases":238,"briefSummary":240,"conditions":241,"keywords":243,"overallStatus":248,"whyStopped":20,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":253,"completionDateStruct":255,"leadSponsor":257,"locationsCount":258},{"fullName":5,"class":6},"Janssen Infectious Diseases BVBA","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"TMC207","EXPERIMENTAL","TMC207 400mg once daily for 2 weeks then 200mg three times a week for 22 weeks in addition to Background Regimen (BR) for the treatment of multi-drug resistant tuberculosis (MDR-TB).",[13,14],"Drug: TMC207","Drug: Background Regimen (BR) for MDR-TB",[16,21],{"type":17,"name":9,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","TMC207 400mg once daily for 2 weeks then 200mg three times a week for 22 weeks.",[9],null,{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":20},"Background Regimen (BR) for MDR-TB","Background Regimen (BR) of antibacterial drugs used in the treatment of TB according to national TB program and selected at the baseline visit as specified in the protocol for up to 96 weeks.",[9],[26],{"name":27,"affiliation":5,"role":28},"Janssen Infectious Diseases BVBA Clinical Trial","STUDY_DIRECTOR",[30,40,47,54,61,68,72,79,88,92,101,108,117,126,133,140,144,151,158,166,173,177,184,192,199,208,215],{"facility":20,"status":20,"city":31,"state":20,"zip":20,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":20},"Beijing","China","CN",{"type":35,"coordinates":36},"Point",[37,38],116.39723,39.9075,{"lat":38,"lon":37},{"facility":20,"status":20,"city":41,"state":20,"zip":20,"country":32,"countryCode":33,"cosmosGeoPoint":42,"geoPoint":46,"contacts":20},"Fuzhou",{"type":35,"coordinates":43},[44,45],119.30611,26.06139,{"lat":45,"lon":44},{"facility":20,"status":20,"city":48,"state":20,"zip":20,"country":32,"countryCode":33,"cosmosGeoPoint":49,"geoPoint":53,"contacts":20},"Jinan",{"type":35,"coordinates":50},[51,52],116.99722,36.66833,{"lat":52,"lon":51},{"facility":20,"status":20,"city":55,"state":20,"zip":20,"country":32,"countryCode":33,"cosmosGeoPoint":56,"geoPoint":60,"contacts":20},"Nanjing",{"type":35,"coordinates":57},[58,59],118.77778,32.06167,{"lat":59,"lon":58},{"facility":20,"status":20,"city":62,"state":20,"zip":20,"country":32,"countryCode":33,"cosmosGeoPoint":63,"geoPoint":67,"contacts":20},"Shanghai",{"type":35,"coordinates":64},[65,66],121.45806,31.22222,{"lat":66,"lon":65},{"facility":20,"status":20,"city":69,"state":20,"zip":20,"country":70,"countryCode":71,"cosmosGeoPoint":20,"geoPoint":20,"contacts":20},"Talinn","Estonia","EE",{"facility":20,"status":20,"city":73,"state":20,"zip":20,"country":70,"countryCode":71,"cosmosGeoPoint":74,"geoPoint":78,"contacts":20},"Tartu",{"type":35,"coordinates":75},[76,77],26.72509,58.38062,{"lat":77,"lon":76},{"facility":20,"status":20,"city":80,"state":20,"zip":20,"country":81,"countryCode":82,"cosmosGeoPoint":83,"geoPoint":87,"contacts":20},"Nairobi","Kenya","KE",{"type":35,"coordinates":84},[85,86],36.81667,-1.28333,{"lat":86,"lon":85},{"facility":20,"status":20,"city":89,"state":20,"zip":20,"country":90,"countryCode":91,"cosmosGeoPoint":20,"geoPoint":20,"contacts":20},"Stopinu Region","Latvia","LV",{"facility":20,"status":20,"city":93,"state":20,"zip":20,"country":94,"countryCode":95,"cosmosGeoPoint":96,"geoPoint":100,"contacts":20},"Callao","Peru","PE",{"type":35,"coordinates":97},[98,99],-77.13452,-12.05162,{"lat":99,"lon":98},{"facility":20,"status":20,"city":102,"state":20,"zip":20,"country":94,"countryCode":95,"cosmosGeoPoint":103,"geoPoint":107,"contacts":20},"Lima",{"type":35,"coordinates":104},[105,106],-77.02824,-12.04318,{"lat":106,"lon":105},{"facility":20,"status":20,"city":109,"state":20,"zip":20,"country":110,"countryCode":111,"cosmosGeoPoint":112,"geoPoint":116,"contacts":20},"Quezon City","Philippines","PH",{"type":35,"coordinates":113},[114,115],121.0509,14.6488,{"lat":115,"lon":114},{"facility":20,"status":20,"city":118,"state":20,"zip":20,"country":119,"countryCode":120,"cosmosGeoPoint":121,"geoPoint":125,"contacts":20},"Arkhangelsk","Russia","RU",{"type":35,"coordinates":122},[123,124],40.55183,64.5461,{"lat":124,"lon":123},{"facility":20,"status":20,"city":127,"state":20,"zip":20,"country":119,"countryCode":120,"cosmosGeoPoint":128,"geoPoint":132,"contacts":20},"Moscow",{"type":35,"coordinates":129},[130,131],37.61781,55.75204,{"lat":131,"lon":130},{"facility":20,"status":20,"city":134,"state":20,"zip":20,"country":119,"countryCode":120,"cosmosGeoPoint":135,"geoPoint":139,"contacts":20},"Oryol",{"type":35,"coordinates":136},[137,138],36.0791,52.96879,{"lat":138,"lon":137},{"facility":20,"status":20,"city":141,"state":20,"zip":20,"country":142,"countryCode":143,"cosmosGeoPoint":20,"geoPoint":20,"contacts":20},"Bellville West Cape","South Africa","ZA",{"facility":20,"status":20,"city":145,"state":20,"zip":20,"country":142,"countryCode":143,"cosmosGeoPoint":146,"geoPoint":150,"contacts":20},"Durban",{"type":35,"coordinates":147},[148,149],31.0292,-29.8579,{"lat":149,"lon":148},{"facility":20,"status":20,"city":152,"state":20,"zip":20,"country":142,"countryCode":143,"cosmosGeoPoint":153,"geoPoint":157,"contacts":20},"Sandringham",{"type":35,"coordinates":154},[155,156],28.11058,-26.14542,{"lat":156,"lon":155},{"facility":20,"status":20,"city":159,"state":20,"zip":20,"country":160,"countryCode":20,"cosmosGeoPoint":161,"geoPoint":165,"contacts":20},"Seoul","South Korea",{"type":35,"coordinates":162},[163,164],126.9784,37.566,{"lat":164,"lon":163},{"facility":20,"status":20,"city":167,"state":20,"zip":20,"country":160,"countryCode":20,"cosmosGeoPoint":168,"geoPoint":172,"contacts":20},"Suwon",{"type":35,"coordinates":169},[170,171],127.00889,37.29111,{"lat":171,"lon":170},{"facility":20,"status":20,"city":174,"state":20,"zip":20,"country":175,"countryCode":176,"cosmosGeoPoint":20,"geoPoint":20,"contacts":20},"Nakhon","Thailand","TH",{"facility":20,"status":20,"city":178,"state":20,"zip":20,"country":175,"countryCode":176,"cosmosGeoPoint":179,"geoPoint":183,"contacts":20},"Nonthaburi",{"type":35,"coordinates":180},[181,182],100.51477,13.86075,{"lat":182,"lon":181},{"facility":20,"status":20,"city":185,"state":20,"zip":20,"country":186,"countryCode":20,"cosmosGeoPoint":187,"geoPoint":191,"contacts":20},"Istanbul","Turkey (Türkiye)",{"type":35,"coordinates":188},[189,190],28.94966,41.01384,{"lat":190,"lon":189},{"facility":20,"status":20,"city":193,"state":20,"zip":20,"country":186,"countryCode":20,"cosmosGeoPoint":194,"geoPoint":198,"contacts":20},"Keçiören",{"type":35,"coordinates":195},[196,197],32.87238,40.00132,{"lat":197,"lon":196},{"facility":20,"status":20,"city":200,"state":20,"zip":20,"country":201,"countryCode":202,"cosmosGeoPoint":203,"geoPoint":207,"contacts":20},"Donetsk","Ukraine","UA",{"type":35,"coordinates":204},[205,206],37.80224,48.023,{"lat":206,"lon":205},{"facility":20,"status":20,"city":209,"state":20,"zip":20,"country":201,"countryCode":202,"cosmosGeoPoint":210,"geoPoint":214,"contacts":20},"Kiev",{"type":35,"coordinates":211},[212,213],30.5238,50.45466,{"lat":213,"lon":212},{"facility":20,"status":20,"city":216,"state":20,"zip":20,"country":201,"countryCode":202,"cosmosGeoPoint":217,"geoPoint":221,"contacts":20},"Odesa",{"type":35,"coordinates":218},[219,220],30.74383,46.48572,{"lat":220,"lon":219},{"type":223,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100126203","phase-2-to-evaluate-the-safety-tolerability-and-efficacy-of-tmc207-as-part-of-an-individualized-multi-drug-resistant-tuberculosis-mdr-tb-treatment-regimen-in-participants-with-sputum-smear-positive-pulmonary-mdr-tb-100126203",true,"NCT00910871","To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.","A Phase II, Open-label Trial With TMC207 as Part of a Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Subjects With Sputum Smear-positive Pulmonary Infection With MDR-TB.","Inclusion Criteria:\n\n* Females of child-bearing potential must be using and are willing to continue using effective birth control methods, or be willing to practice sexual abstinence throughout treatment or be nonheterosexual active\n* Confirmed pulmonary MDR-TB infection including those infected with XDR (extensively drug resistant)-TB\n* Positive for acid-fast bacilli (AFB) on direct smear examination of expectorated sputum specimen (= 1+ smear-positive)\n* HIV-positive patients are eligible, provided they meet the requirements as described in the protocol\n* Must voluntarily sign the Informed Consent Form (ICF) prior to starting any study activities\n* Willing to comply with protocol requirements\n* Willing to comply with NTP treatment guidelines\n\nExclusion Criteria:\n\n* Patients having a known or suspected hypersensitivity or serious adverse reaction to TMC207\n* Patients with significant cardiac arrhythmia requiring medication\n* Patients with complicated or severe extrapulmonary manifestations of TB, including central nervous system infection\n* Patients with certain QT\u002FQTc interval characteristics as described in the protocol\n* Patients having participated in other clinical studies with investigational agents, within 8 weeks prior to trial start\n* Women who are pregnant or breastfeeding\n* Patients who have previously received treatment with TMC207 as part of a clinical trial.",false,"ALL","18 Years",{"count":235,"type":236},241,"ACTUAL","INTERVENTIONAL",[239],"PHASE2","The purpose of this study is to evaluate the safety, tolerability and effectiveness of TMC207 in combination with an individualized background regimen (BR) of antibacterial drugs as treatment for MDR-TB",[242],"Tuberculosis",[242,244,245,9,246,247],"TMC207-TiDP13-C209","TMC207-C209","TB","MDR-TB","COMPLETED","2015-04-08",{"date":251,"type":252},"2015-04-24","ESTIMATED",{"date":254,"type":20},"2009-09",{"date":256,"type":236},"2013-01",{"name":5,"class":6},27]